Arkolith/Insider Trading/TXG/Form 4

Saxonov Serge

Chief Executive Officer, Director10x Genomics, Inc. (TXG) · full profile →Form 4 · filed Jan 7, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2026Option exercise(M)50K$1.20$60K1.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 5, 2026Option exercise(M)33K—$0174K
Jan 5, 2026Option exercise(M)17K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-26-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML